Valuation: Haleon plc

Market Cap 32.68B 43.86B 38.44B 35.53B 61.66B 4,229B 62.65B 425B 167B 2,069B 165B 161B 7,130B P/E 2026 *
19.2x
P/E 2027 * 17.3x
Enterprise Value 39.59B 53.14B 46.57B 43.05B 74.71B 5,124B 75.91B 515B 202B 2,507B 200B 195B 8,638B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.29x
Free-Float
99.42%
Yield 2026 *
2.15%
Yield 2027 * 2.4%
1 day-0.62%
1 week+1.64%
Current month+6.70%
1 month+11.08%
3 months+4.21%
6 months-0.51%
Current year-1.01%
1 week 354.1
Extreme 354.1
377.5
1 month 329.3
Extreme 329.3
377.5
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
5/19/26 Buy 24,891 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.62%+1.64%+3.43%+11.44% 44.24B
-2.73%-2.96%+48.62%+147.27% 1,051B
-1.67%-3.47%+52.00%+47.77% 609B
-0.44%+2.17%+33.88%+78.20% 450B
-0.75%+0.30%+28.32%+21.15% 330B
-1.52%-1.19%+33.38%+35.35% 284B
-1.70%-1.82%+20.26%+15.74% 263B
-0.58%+1.11%-20.89%-40.59% 223B
-0.58%+1.03%+23.55%+56.14% 198B
-0.80%+1.38%+23.09%+66.64% 167B
Average -0.74%+0.02%+24.56%+43.91% 361.93B
Weighted average by Cap. -0.89%-1.04%+34.86%+70.15%

Financials

2026 *2027 *
Net sales 11.4B 15.3B 13.41B 12.39B 21.51B 1,475B 21.85B 148B 58.1B 722B 57.44B 56.19B 2,487B 11.89B 15.96B 13.99B 12.93B 22.44B 1,539B 22.8B 155B 60.6B 753B 59.92B 58.61B 2,594B
Net income 1.74B 2.34B 2.05B 1.9B 3.29B 226B 3.34B 22.66B 8.88B 110B 8.78B 8.59B 380B 1.9B 2.55B 2.24B 2.07B 3.59B 246B 3.64B 24.72B 9.69B 120B 9.58B 9.37B 415B
Net Debt 6.91B 9.28B 8.13B 7.52B 13.05B 895B 13.25B 89.89B 35.24B 438B 34.84B 34.08B 1,508B 6.4B 8.59B 7.53B 6.96B 12.08B 829B 12.28B 83.26B 32.64B 406B 32.27B 31.57B 1,397B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (29.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (22.8%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (17.7%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - vitamins, minerals and food supplements (15.1%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. - respiratory medicines (14.9%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.2%), North America (36%), and Asia/Pacific (22.8%).
Employees
24,535
Date Price Change Volume
26-07-20 GBX 371.00 -0.62% 18,087,141
26-07-17 GBX 373.30 +0.86% 20,562,834
26-07-16 GBX 370.10 +3.03% 17,624,000
26-07-15 GBX 359.20 -0.31% 22,047,851
26-07-14 GBX 360.30 -1.29% 11,985,968
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.710GBP
Average target price
4.142GBP
Spread / Average Target
+11.65%

Quarterly revenue - Rate of surprise